New position is a significant step toward
delivering on value added, science-based differentiation
strategy
LAVAL, QC, April 10, 2019 /CNW Telbec/ - Neptune
Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ:
NEPT) (TSX: NEPT) is pleased to announce today that Dr.
Graham Wood will be joining the
Company's management team as Chief Scientific Officer (CSO) as of
May 1st, 2019.
With the creation of this new position, Neptune takes a
significant step further in executing on its strategy toward global
leadership in the offering of value added, differentiated
science-based products for the legal cannabis and nutrition
consumer product markets.
Dr. Wood, holder of a Ph.D. in Neurology and Neurosurgery from
McGill University, is a distinguished researcher and executive
and a recognized leader in the clinical pharmacology of cannabis
with experience with combustible, vaping, sublingual and oral
oils and capsules formulations of cannabis. He has conducted over
400 clinical pharmacology studies with companies such as Phoenix
International, MDS Pharma, Allied Research and Cetero and was CEO
at Manna Research (a late phase clinical CRO). He was most recently
Chief R&D Officer at Altasciences, where he led cannabis
research.
"We are delighted to welcome someone of Graham's stature to
steer our scientific efforts. Both cannabis and nutrition are
global consumer product industries that hinge on value-added,
differentiated and science-based products and Graham's proven
expertise will be invaluable in supporting Neptune's leading
capabilities in this regard," said Jim
Hamilton, President and CEO of Neptune.
"Science is key to the development of effective
condition-specific cannabinoid products for medical, wellness and
lifestyle consumers. I am excited to join Neptune, whose
long-standing experience in the health and wellness consumer
product sector makes it ideally positioned to thrive in the global
marketplace as the cannabis and the health and nutrition markets
become increasingly intertwined", said Wood.
As CSO, Wood will lead Neptune's research and development
strategy, product development efforts and clinical programs. Wood
will also oversee Neptune's global regulatory strategy, health
product delivery technologies, and intellectual property
portfolio.
About Neptune Wellness Solutions Inc.
Neptune
Wellness Solutions specializes in the extraction, purification and
formulation of health and wellness products. Licensed by Health
Canada to process cannabis at its 50,000 square foot facility
located in Sherbrooke, Quebec,
Neptune brings decades of experience in the natural products sector
to the legal cannabis industry. Leveraging its scientific and
technological expertise, Neptune focuses on the development of
value-added and differentiated products for the Canadian and global
cannabis markets. Neptune's activities also include the development
and commercialization of turnkey nutrition solutions and patented
ingredients such as MaxSimil®, and of a variety of marine and seed
oils. Its head office is located in Laval, Quebec.
Forward Looking Statements
Statements in this press release that are not statements of
historical or current fact constitute "forward-looking statements"
within the meaning of the U.S. securities laws and Canadian
securities laws. Such forward-looking statements involve known and
unknown risks, uncertainties, and other unknown factors that could
cause the actual results of Neptune to be materially different from
historical results or from any future results expressed or implied
by such forward-looking statements. In addition to statements which
explicitly describe such risks and uncertainties, readers are urged
to consider statements labeled with the terms "believes", "belief",
"expects", "intends", "projects", "anticipates", "will", "should"
or "plans" to be uncertain and forward-looking. Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date of this press release.
Forward-looking information in this press release includes, but is
not limited to, information or statements about our ability to
successfully develop, produce, supply, promote or generate any
revenue from the sale of any cannabis-based products in the legal
cannabis market.
The forward-looking statements contained in this press
release are expressly qualified in their entirety by this
cautionary statement and the "Cautionary Note Regarding
Forward-Looking Information" section contained in Neptune's latest
Annual Information Form (the "AIF"), which also forms part of
Neptune's latest annual report on Form 40-F, and which is available
on SEDAR at www.sedar.com, on EDGAR at
www.sec.gov/edgar.shtml and on the investor section of
Neptune's website at www.neptunecorp.com. All forward-looking
statements in this press release are made as of the date of this
press release. Neptune does not undertake to update any such
forward-looking statements whether as a result of new information,
future events or otherwise, except as required by law. The
forward-looking statements contained herein are also subject
generally to other risks and uncertainties that are described from
time to time in Neptune public securities filings with the
Securities and Exchange Commission and the Canadian securities
commissions. Additional information about these assumptions and
risks and uncertainties is contained in the AIF under "Risk
Factors".
Neither NASDAQ nor the Toronto Stock Exchange accepts
responsibility for the adequacy or accuracy of this
release.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/neptune-welcomes-dr-graham-wood-as-chief-scientific-officer-300829766.html
SOURCE Neptune Wellness Solutions Inc.